ExitValue.ai

Pharmacy Valuation Calculator

Backed by 237 real disclosed pharmacyM&A transactions. Run the full M&A-grade workup in about two minutes.

Value your pharmacy

12-input M&A-grade workup with sellability score, named comparable deals, and AI-written commentary. 2 minutes.

  • ✓Sellability score with 5-driver breakdown and lift estimates
  • ✓Named comparable M&A transactions in your sub-vertical
  • ✓AI-written analysis grounded in your specific inputs
Run my valuation analysis →

What this calculator is built on

Disclosed deals analyzed

237

pharmacy M&A transactions

Current market

stable

pharmacy trend

Sources

SEC + verified

EDGAR 8-K / S-4 / press

Refresh cadence

Nightly

EDGAR ingest 06:00 UTC

Multiples paid for pharmacy businesses unlock when you run the calculator above - the range is built from these deals.

How this calculator works

The pharmacy calculator analyzes 237 disclosed M&A transactions in our database against your inputs, then applies adjustments specific to pharmacy businesses (margin vs the vertical median, growth trend, recurring revenue mix, owner dependency, customer concentration). Output is a tight range around the most-likely transaction value, with the underlying multiples revealed on the results page.

What drives premium multiples in pharmacy

  • Specialty / compounding mix above 30% (PBM rate cuts hit retail not specialty)
  • LTC / closed-door book or 340B participation (recurring institutional revenue)
  • URAC or ACHC accreditation in place (PE platform prerequisite, not optional)

What compresses pharmacy multiples

  • Pure retail / generic-substitution exposure (PBM reimbursement compression priced in)
  • DIR fee exposure trending up (margin compression unfixable at single-location scale)
  • Single-payer concentration above 50% (PBM contract loss = practice unviability)

More on pharmacy valuations

Backed by 25,592 disclosed transactions from SEC filings, EDGAR 8-K/S-4, and verified press releases · methodology